Incyte Business Operations Contracts & Agreements
7 Contracts & Agreements
- Collaboration Agreements (7 contracts)
- Amendment No. 3, dated as of July 14, 2022, to Global Collaboration and License Agreement, dated October 24, 2017, by and between the Company and MacroGenics, Inc (Filed With SEC on November 1, 2022)
- Amendment No. 2, dated as of April 7, 2022, to Global Collaboration and License Agreement, dated October 24, 2017, by and between the Company and MacroGenics, Inc (Filed With SEC on August 2, 2022)
- Second Amendment, dated as of January 8, 2021, to Collaboration and License Agreement entered into as of January 12, 2020 by and among the Company, MorphoSys AG and MorphoSys US,... (Filed With SEC on May 4, 2021)
- First Amendment, dated as of July 17, 2020, to Collaboration and License Agreement entered into as of January 12, 2020 by and among the Company, MorphoSys AG and MorphoSys US Inc (Filed With SEC on February 9, 2021)
- Amendment No. 1, dated as of March 15, 2018, to Global Collaboration and License Agreement, dated October 24, 2017, by and between the Company and MacroGenics, Inc (Filed With SEC on May 1, 2018)
- AMENDMENT NO. 4 TO COLLABORATION AND LICENSE AGREEMENT (Filed With SEC on August 9, 2016)
- LICENSE AND COLLABORATION AGREEMENT BY AND BETWEEN INCYTE EUROPE SARL AND JIANGSU HEnGRUI MEDICINE CO., LTD. SEPTEMBER 1, 2015 (Filed With SEC on November 3, 2015)
